-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Initiates Coverage On Praxis Precision Medicine with Overweight Rating, Announces Price Target of $700

Benzinga·10/16/2026 13:37:52
语音播报
JP Morgan analyst Tessa Romero initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Overweight rating and announces Price Target of $700.